Cargando…
Setting the Beta-Lactam Therapeutic Range for Critically Ill Patients: Is There a Floor or Even a Ceiling?
OBJECTIVES: Beta-lactam antibiotics exhibit high interindividual variability in drug concentrations in patients with critical illness which led to an interest in the use of therapeutic drug monitoring to improve effectiveness and safety. To implement therapeutic drug monitoring, it is necessary to d...
Autores principales: | Barreto, Erin F., Webb, Andrew J., Pais, Gwendolyn M., Rule, Andrew D., Jannetto, Paul J., Scheetz, Marc H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202642/ https://www.ncbi.nlm.nih.gov/pubmed/34136822 http://dx.doi.org/10.1097/CCE.0000000000000446 |
Ejemplares similares
-
Provider perspectives on beta-lactam therapeutic drug monitoring programs in the critically ill: a protocol for a multicenter mixed-methods study
por: Barreto, Erin F., et al.
Publicado: (2021) -
743. Implementation of Beta-Lactam Therapeutic Drug Monitoring Programs in the Critically Ill: A Multicenter Mixed-Methods Study
por: Ausman, Sara, et al.
Publicado: (2022) -
Floor and ceiling effects in the OHS: an analysis of the NHS PROMs data set
por: Lim, Christopher R, et al.
Publicado: (2015) -
318. Beta-lactam Therapeutic Drug Monitoring Improves Attainment of Target Drug Levels in Critically Ill Patients
por: Ausman, Sara, et al.
Publicado: (2023) -
Utility of Huntington's Disease Assessments by Disease Stage: Floor/Ceiling Effects
por: Abreu, Daisy, et al.
Publicado: (2021)